Literature DB >> 29458795

Mucins: Structural diversity, biosynthesis, its role in pathogenesis and as possible therapeutic targets.

Suresh Sulekha Dhanisha1, Chandrasekharan Guruvayoorappan2, Sudarsanan Drishya1, Prathapan Abeesh1.   

Abstract

Mucins are the main structural components of mucus that create a selective protective barrier for epithelial surface and also execute wide range of other physiological functions. Mucins can be classified into two types, namely secreted mucins and membrane bounded mucins. Alterations in mucin expression or glycosylation and mislocalization have been seen in various types of pathological conditions such as cancers, inflammatory bowel disease and ocular disease, which highlight the importance of mucin in maintaining homeostasis. Hence mucins can be used as attractive target for therapeutic intervention. In this review, we discuss in detail about the structural diversity of mucins; their biosynthesis; its role in pathogenesis; regulation and as possible therapeutic targets.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Pathogenesis; Secreted mucins; Therapeutic agents; Transmembrane mucins

Mesh:

Substances:

Year:  2017        PMID: 29458795     DOI: 10.1016/j.critrevonc.2017.12.006

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  44 in total

Review 1.  When Glycosylation Meets Blood Cells: A Glance of the Aberrant Glycosylation in Hematological Malignancies.

Authors:  Huining Su; Mimi Wang; Xingchen Pang; Feng Guan; Xiang Li; Ying Cheng
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

2.  Untouchable genes in the human genome: Identifying ideal targets for cancer treatment.

Authors:  Ivan P Gorlov; Olga Y Gorlova; Christopher I Amos
Journal:  Cancer Genet       Date:  2019-01-24

3.  Interactions of commensal and pathogenic microorganisms with the mucus layer in the colon.

Authors:  Rui Cai; Chen Cheng; Jianwei Chen; Xiaoqiang Xu; Chao Ding; Bing Gu
Journal:  Gut Microbes       Date:  2020-03-29

Review 4.  Sticking to the Problem: Engineering Adhesion in Molecular Endoscopic Imaging.

Authors:  Mahboubeh S Noori; Sarah J Bodle; Christian A Showalter; Evan S Streator; David S Drozek; Monica M Burdick; Douglas J Goetz
Journal:  Cell Mol Bioeng       Date:  2020-01-21       Impact factor: 2.321

5.  Stable recombinant production of codon-scrambled lubricin and mucin in human cells.

Authors:  Carolyn R Shurer; Yuyan Wang; Elizabeth Feeney; Shelby E Head; Victoria X Zhang; Jin Su; Zhu Cheng; Morgan A Stark; Lawrence J Bonassar; Heidi L Reesink; Matthew J Paszek
Journal:  Biotechnol Bioeng       Date:  2019-03-08       Impact factor: 4.530

Review 6.  Unraveling mucin domains in cancer and metastasis: when protectors become predators.

Authors:  Koelina Ganguly; Sanchita Rauth; Saravanakumar Marimuthu; Sushil Kumar; Surinder K Batra
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

7.  Mucin pre-cultivated Lactobacillus reuteri E shows enhanced adhesion and increases mucin expression in HT-29 cells.

Authors:  Boris Dudík; Hana Kiňová Sepová; František Bilka; Ľudmila Pašková; Andrea Bilková
Journal:  Antonie Van Leeuwenhoek       Date:  2020-05-14       Impact factor: 2.271

Review 8.  Current and future roles of mucins in cholangiocarcinoma-recent evidences for a possible interplay with bile acids.

Authors:  Elisa Danese; Andrea Ruzzenente; Martina Montagnana; Patricia Marie-Jeanne Lievens
Journal:  Ann Transl Med       Date:  2018-09

Review 9.  The Relationship between Mucins and Ulcerative Colitis: A Systematic Review.

Authors:  Esther Bankole; Emily Read; Michael A Curtis; Joana F Neves; James A Garnett
Journal:  J Clin Med       Date:  2021-04-30       Impact factor: 4.241

Review 10.  Human ocular mucins: The endowed guardians of sight.

Authors:  Pablo Argüeso
Journal:  Adv Drug Deliv Rev       Date:  2021-12-04       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.